Reporte zur Charge FH8028212822

Symptomtext

breast swelling; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Nov2021 as dose 3 (booster), single (Lot number: FH8028212822) at the age of 55 years for covid-19 immunisation. The patient's relevant medical history included: "Yes--I have predicatable immune responses to all vaccines" (unspecified if ongoing), notes: Yes--I have predicatable immune responses to all vaccines. This is different. Environmental; "Environmental" (unspecified if ongoing), notes: Yes--I have predicatable immune responses to all vaccines. This is different. Environmental. Concomitant medication(s) included: ZOCOR. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EJ1685, ), administration date: 22Dec2020, when the patient was 55-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE, Lot number: EL3248, ), administration date: 12Jan2021, when the patient was 55-year-old, for Covid-19 Immunization. The following information was reported: BREAST SWELLING (non-serious), outcome "unknown". Follow-Up (26Oct2022): Follow-up attempts are completed. No further information is expected.